Michael Cowley

  • Regional Editors

    Monash University
    Department of Physiology
    Clayton, VIC, Australia

  • Michael Cowley, PhD, is the founding director of the Monash Obesity & Diabetes Institute and Professor of Physiology at Monash University. He is also director of an Australian diabetes drug development company, Verva Inc., and founder of Orexigen Therapeutics, a San Diego biotech company where he served as the Chief Scientific Officer until December 2008.